Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2006 Dec 5;27(8):459–463. doi: 10.1002/clc.4960270808

Effectiveness of enhanced external counterpulsation in patients with left main disease and angina

William E Lawson 1,, John C K Hui 1, Gregory W Barsness 2, Elizabeth D Kennard 3, Sheryl F Kelsey 3
PMCID: PMC6654733  PMID: 15346843

Abstract

Background: Enhanced external counterpulsation (EECP) is a noninvasive device that uses three pairs of sequentially inflated pneumatic cuffs applied to the lower extremities and synchronized with the heart beat to provide diastolic augmentation, increase coronary blood pressure and flow, venous return and cardiac output, and decrease afterload.

Hypothesis: This study examines the safety and effectiveness of EECP therapy in patients with significant left main coronary artery disease (LMD).

Methods: In all, 2,861 patients enrolled in the International EECP Patient Registry (IEPR) were divided into three groups, those without LMD (n = 2,377), those with LMD and prior CABG (n = 431), and those with unbypassed LMD (n = 53).

Results: Patients with LMD, with or without prior CABG, were significantly more likely to have triple‐vessel disease (98.1 and 88.7%, respectively) than patients without LMD (41.9%). Post‐EECP, 74% without LMD, 75% with LMD with prior CABG, and 65% with unbypassed LMD improved their Canadian Cardiovascular Society (CCS) angina by at least one class (p = NS). There were no differences in the mean decrease in weekly angina episodes (7.1 vs. 8.0 vs. 7.6) and in the mean frequency of weekly nitroglycerinuse (6.6 vs. 8.1 vs. 8.9). At 6‐month follow‐up, the CCS class improved further in all three groups, and there was a further reduction in mean weekly angina episodes (4.7 vs. 4.6 vs. 5.3) and nitroglycerinuse (6.5 vs. 6.8 vs. 8.2). Kaplan‐Meier life table analysis 8 months after starting EECP demonstrated a major cardiovascular event rate of 11.2% in patients without LMD, 15.6% in LMD with CABG, and 24.3% in LMD without prior CABG. Late mortality in unbypassed LMD was 13.2% (confidence interval [CI] 3.3‐23.1) versus 4.8% (CI 2.7‐7.1) in LMD with CABG, and 2.8% (CI 2.1‐3.5) without LMD (p = 0.0039 by log‐rank test).

Conclusion: Enhanced external counterpulsation is equally effective in relieving angina in patients with or without LMD. However, the significantly increased late mortality in patients with LMD without prior CABG suggests that early revascularization should be considered in these patients.

Keywords: left main disease, enhanced external counterpulsation, angina

Full Text

The Full Text of this article is available as a PDF (74.9 KB).

References

  • 1. Lawson WE, Hui JCK, Soroff HS, Zheng ZS, Kayden DS, Sasvary D, Atkins H, Cohn PF: Efficacy of enhanced external counterpulsation in the treatment of angina pectoris. Am J Cardiol 1992; 10: 859–862 [DOI] [PubMed] [Google Scholar]
  • 2. Suresh K, Simandl S, Lawson WE: Maximizing the hemodynamic benefit of enhanced external counterpulsation. Clin Cardiol 1998; 21: 649–653 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Taguchi I, Ogawa K, Oida A, Abe S, Kaneko N, Sakio H: Comparison of hemodynamic effects of enhanced external counterpulsation and intra‐aortic balloon pumping in patients with acute myocardial infarction. Am J Cardiol 2000; 86: 1139–1141 [DOI] [PubMed] [Google Scholar]
  • 4. Michaels AD, Accad M, Ports TA, Grossman W: Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation. Circulation 2002; 106: 1237–1242 [DOI] [PubMed] [Google Scholar]
  • 5. Lawson WE, Hui JCK, Lang G: Treatment benefit in the enhanced external counterpulsation consortium. Cardiology 2000; 94: 31–35 [DOI] [PubMed] [Google Scholar]
  • 6. Lawson WE, Hui JCK: Enhanced external counterpulsation for chronic myocardial ischemia. J Crit Illness 2000; 15 (11): 629–636 [Google Scholar]
  • 7. Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, Nesto R: The multicenter study of enhanced external counterpulsation (MUST‐EECP): Effect of EECP on exercise‐induced myocardial ischemia and anginal episodes. J Am Coll Cardiol 1999; 33: 1833–1840 [DOI] [PubMed] [Google Scholar]
  • 8. Urano H, Ikeda H, Ueno T, Matsumoto T, Murohara T, Imaizumi T: Enhanced external counterpulsation improves exercise tolerance, reduces exercise‐induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol 2001; 37: 93–99 [DOI] [PubMed] [Google Scholar]
  • 9. Fricchione GL, Jaghab K, Lawson WE, Hui JCK, Jandorf L, Zheng ZS, Cohn PF, Soroff H: Psychosocial effects of enhanced external counterpulsation in the angina patient. Psychosomatics 1995; 77: 494–497 [DOI] [PubMed] [Google Scholar]
  • 10. Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, Nesto R, Ferrans CE, Keller S: Effects of enhanced external counterpulsation on health‐related quality of life continue 12 months after treatment: A substudy of the Multicenter Study of Enhanced External Counterpulsation. J Invest Med 2002; 50: 25–32 [DOI] [PubMed] [Google Scholar]
  • 11. Stys TP, Lawson WE, Hui JCK, Fleishman B, Manzo K, Strobeck JE, Tartaglia J, Ramasamy S, Suwita R, Zheng ZS, Liang H, Werner D: Effects of enhanced external counterpulsation on stress radionuclide coronary per‐fusion and exercise capacity in chronic stable angina pectoris. Am J Cardiol 2002; 89: 822–824 [DOI] [PubMed] [Google Scholar]
  • 12. Masuda D, Nohara R, Inada H, Hirai T, Li‐Guang C, Kanda H, Inubushi M, Tadamura E, Fujita M, Sasayama S: Improvement of regional myocardial and coronary blood flow reserve in a patient treated with enhanced external counterpulsation: Evaluation by nitrogen‐13 ammonia PET ‐. Jpn Circ J 1999; 63: 407–411 [DOI] [PubMed] [Google Scholar]
  • 13. Lawson WE, Hui JC, Cohn PF: Long‐term prognosis of patients with angina treated with enhanced external counterpulsation: Five‐year follow‐up study. Clin Cardiol 2000; 23: 254–258 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Lawson W, Hui J, Guo T, Burger L, Cohn PF: Prior revascularization increases the effectiveness of enhanced external counterpulsation. Clin Cardiol 1998; 21: 841–844 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Lawson WE, Hui JCK, Zheng ZS, Burger L, Jiang L, Lillis O, Soroff HS, Cohn PF: Improved exercise tolerance following enhanced external counterpulsation: Cardiac or peripheral effect? Cardiology 1996; 87: 271–275 [DOI] [PubMed] [Google Scholar]
  • 16. Wu GF, Qiang SZ, Zheng ZS, Zhang MQ, Lawson WE, Hui JCK: A neuro‐hormonal mechanism for the effectiveness of enhanced external counterpulsation. Circulation 1999; 100 (18): I–832 (#4390) [Google Scholar]
  • 17. Bonetti PO, Barsness GW, Keelan PC, Schnell TI, Pumper GM, Kuvin JT, Schnall RP, Holmes DR, Higano ST, Lerman A: Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003; 41: 1761–1768 [DOI] [PubMed] [Google Scholar]
  • 18. Barsness G, Feldman AM, Holmes DR, Holubkov R, Kelsey SF, Kennard ED, and the IEPR Investigators : The International EECP Patient Registry (IEPR): Design, methods, baseline characteristics, and acute results. Clin Cardiol 2001; 24: 435–442 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Conley MJ, Ely RL, Kisslo J, Lee KL, McNeer JF, Rosati RA: The prognostic spectrum of left main stenosis. Circulation 1978; 57: 947–952 [DOI] [PubMed] [Google Scholar]
  • 20. Dacosta A, Tardy B, Favre JP, Guy JM, Rachet F, Lamaud M, Barral X, Verneyre H: La pathologie du tronc coronaire gauche. Arch Mal Coeur 1994; 87: 1225–1232 [PubMed] [Google Scholar]
  • 21. Silvestri M, Barragan P, Sainsous J, Bayet G, Simeoni J‐B, Roquebert P‐O, Macaluso G, Bouvier J‐L, Comet B: Unprotected left main coronary artery stenting: Immediate and medium‐term outcomes of 140 elective procedures. J Am Coll Cardiol 2000; 35: 1543–1550 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES